China Reform Health Management and Services Group Co., Ltd.

China Reform Health Management and Services Group Co., Ltd.

000503.SZ
China Reform Health Management and Services Group Co., Ltd.CN flagShenzhen Stock Exchange
6.33
CNY
+0.15
- -
6.20BMarket Cap
China Reform Health Management and Services Group Co., Ltd.
000503.SZ
(Shenzhen Stock Exchange)

Recent

price

6.33

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.22
0.18
0.21
0.23
0.22
0.22
0.24
0.21
0.11
0.14
0.23
0.28
0.34
0.36
0.36
0.36
0.32
Revenue per Share
0.01
0.02
0.03
0.01
0.03
0.03
0.03
0.02
-0.21
0.02
-0.27
-0.2
-0.09
-0.09
-0.01
-0.41
-0.04
Basic EPS, GAAP
-0.02
0.07
0.03
0.13
-0.08
-0.07
-0.1
-0.37
-0.07
0.04
-0.12
-0.14
-0.22
-0.17
-0.12
-0.13
-0.04
Free Cash Flow per Basic Share
0.01
- -
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
0.01
0.01
0.01
Dividend per Share
1.35
1.54
1.57
1.58
1.61
1.64
1.67
1.69
1.45
1.47
1.2
1.01
0.91
0.9
0.83
0.41
0.72
Book Value per Share
1.29
1.34
1.36
1.33
1.38
1.38
1.34
1.31
1.11
1.56
0.91
0.71
0.62
1.37
1.25
0.84
1.15
Tangible Book Value per Share
901
900
899
901
898
897
898
896
899
898
899
901
907
911
979
979
980
Basic Weighted Avg Shares
198
163
193
206
195
194
217
184
95
130
207
253
311
330
357
350
315
Sales/Revenue/Turnover
-9.87
-29.18
6.66
0.98
-24.39
-42.3
-51.54
-101.55
-199.42
-16.55
-56.62
-52.57
-35.34
-32.28
-38.68
-40.47
-51.34
Operating Margin (%)
45
36
27
28
20
23
28
34
33
32
32
36
40
34
36
44
- -
Depreciation Expense
12
18
24
13
25
23
28
17
-188
17
-243
-176
-84
-80
-10
-404
-36
Net Income, GAAP
19.22
6.22
36.21
49.96
42.29
76.01
55.35
103.64
- -
3.16
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
6.15
11.05
12.49
6.3
12.8
11.9
12.92
9.06
-196.65
13.42
-116.99
-69.63
-27.11
-24.17
-2.91
-115.28
-11.58
Profit Margin (%)
982
905
879
975
1,051
1,082
1,036
898
734
1,204
691
474
388
1,061
1,038
632
932
Working Capital
5
4
3
3
2
2
1
- -
- -
- -
11
2
3
1
122
160
123
LT Debt
1,295
1,261
1,289
1,272
1,328
1,380
1,413
1,393
1,209
1,603
964
787
713
1,421
1,406
1,008
1,306
Total Equity
-1.11
-3.35
0.62
0.07
-2.02
-1.41
-3.51
0.48
- -
-1.48
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
1.38
1.38
1.48
1.06
2.21
2.47
2.9
2.24
- -
1.5
- -
- -
- -
- -
- -
- -
0.94
Return on Capital (%)
1.01
1.38
1.73
0.92
1.74
1.58
1.89
1.11
-13.33
1.33
-20.22
-17.71
-9.74
-9.71
-1.27
-66.79
-5.02
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
156
156
261
LT Borrowings
- -
- -
- -
LT Finance Leases
122
123
123
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
981
981
981
Market Capitalization
10,762
10,635
10,360

Working Capital

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
1,553
1,478
1,506
Cash, Cash Equivalents & STI
1,313
1,229
1,120
Accounts Receivable, Net
125
109
154
Inventories
1
1
3
Total Current Liabilities
515
490
575
Payables & Accruals
- -
- -
- -
ST Debt
156
156
261
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.26%
8.43%
-28.3%
Free Cash Flow
-31.23%
6.41%
6%
Net Income, GAAP
77.55%
724.36%
3,793.75%
Sales/Revenue/Turnover
10.17%
11.48%
-1.81%
Total Cash Common Dividend
- -
84.97%
-15.49%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
48
89
63
157
357
2025
50
45
180
- -
350
2026
51
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.04
- -
- -
- -
-0.01
2025
-0.05
- -
- -
- -
-0.41
2026
-0.05
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.01
2025
- -
- -
- -
- -
0.01
2026
- -
- -
- -
- -
- -
Business
China Reform Health Management and Services Group Co., Ltd. specializes in health management and healthcare services in China, focusing on medical insurance fund management, medical quality and safety services, drug and device supervision, and health service innovation. The company provides digital medical services, digital medicine, and comprehensive health management through advanced technologies such as artificial intelligence and big data analytics. Its product offerings include medical insurance fee control, medical quality supervision, health data platforms, telemedicine services, and healthcare analytics solutions designed to enhance efficiency, accessibility, and patient outcomes. Founded in 2015 and headquartered in China, the company operates a network of partnerships with over 200 hospitals and clinics across multiple provinces. Recent major developments include the integration of big health data with digital ecology strategies aligned with "Healthy China" and "Three Medicals Coordination" reforms, a significant increase in telehealth and digital patient management services, and strategic acquisitions of healthcare technology firms to strengthen data-driven health solutions. In the last two years, China Reform Health Management has expanded its digital health investments, improved patient engagement by 20%, reduced appointment wait times by 25%, and increased technology-driven revenue to 35% of total revenue. The company also underwent executive changes in 2025 and has been active in forming alliances with pharmaceutical companies to optimize supply chains and reduce operational costs by approximately 20%. Its financial growth reflects a revenue approaching RMB 10.5 billion with a net profit margin around 11.4% for 2023, demonstrating robust operational performance in China's evolving healthcare sector. China Reform Health Management and Services Group plays a critical role in China's healthcare reform initiatives by leveraging technology to promote fair and impartial health security services nationwide.